Bridge Therapeutics®, based in Birmingham, Ala., is an innovative development-stage specialty pharmaceutical company pursuing U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals of a patented (U.S. Patent #8410092) drug combination, BT-205, for the treatment of chro...
Use this information to figure out if this company is an ideal customer for you.
(877) 223-xxxx
217 Country Club Park
Birmingham, 35213
11 - 50 Employees
$5M - $20M
linkedin.com/company/bridge-therapeutics-inc
Bridge Therapeutics Inc.'s CEO is David H Bergstrom
Bridge Therapeutics Inc.'s HQ is located at 217 Country Club Park, Birmingham
Bridge Therapeutics Inc.'s phone number is (877) 223-xxxx
Bridge Therapeutics Inc.'s official website is bridgetherapeutics.com
Bridge Therapeutics Inc.'s revenue is $5M - $20M
Bridge Therapeutics Inc. has 11 - 50 employees
Bridge Therapeutics Inc. is in the industry of: Pharmaceuticals
